L3VLUP
← Every manager
Free · no sign-up · Q2 2026

Which funds own ARQT

Arcutis Biotherapeutics Inc in the Q2 2026 filings. At least 1 of the 91 current managers on file reported a position, worth $4.1m between them. It is among the largest positions of fewer than a fifth of the current managers on file. Buying and selling roughly cancelled this quarter, which is what a name looks like when the argument is still live.

Managers holding
1
at least, of 91 current
Combined value
$4.1m
as reported
Opened
0
new this quarter
Added to
0
already held
Trimmed or sold out
1
1 sold out entirely

Only each manager’s largest 200 positions are listed here, so a smaller holder may be missing.

Managers reporting a position

Largest first. Weight is the share of that manager’s whole reported book, which is the number worth quoting: $400m is a rounding error in one book and a defining bet in another.

ManagerValueWeightSharesChange on the quarterAction
PDT Partners LLC
Quantitative · $1.9bn book
$4.1m0.2%155,075+$400k0Held

Sold out of this quarter

Valued at what the position was worth in the previous filing, because by this one it is gone.

Ownership through time

At least 3 of the 95 managers whose filings are on file listed ARQT in Q2 2026, against 1 in Q4 2020. 2 managers fewer than in Q1 2026: 1 started a position; 1 listed it again; 1 sold out, by its own filing; 3 no longer listed it among the positions read, which can mean a holding below the listed range, a filing that reported no holdings, or a filing not yet made.

Each manager’s largest 500 positions a quarter are read, so a small holding in a very large book can be missing, and a manager is counted as leaving only where its own filing shows it.

Managers on file listing it
035Q4 2020: 1Q1 2021: 121Q2 2021: 1Q3 2021: 1Q4 2021: 2Q1 2022: 222Q2 2022: 1Q3 2022: 3Q4 2022: 4Q1 2023: 423Q2 2023: 4Q3 2023: 3Q1 2024: 424Q2 2024: 5Q3 2024: 3Q4 2024: 4Q1 2025: 325Q2 2025: 5Q3 2025: 4Q4 2025: 4Q1 2026: 526Q2 2026: 3
  • Q4 2020: 1
  • Q1 2021: 1
  • Q2 2021: 1
  • Q3 2021: 1
  • Q4 2021: 2
  • Q1 2022: 2
  • Q2 2022: 1
  • Q3 2022: 3
  • Q4 2022: 4
  • Q1 2023: 4
  • Q2 2023: 4
  • Q3 2023: 3
  • Q1 2024: 4
  • Q2 2024: 5
  • Q3 2024: 3
  • Q4 2024: 4
  • Q1 2025: 3
  • Q2 2025: 5
  • Q3 2025: 4
  • Q4 2025: 4
  • Q1 2026: 5
  • Q2 2026: 3
Their combined reported value
$0$59m$118mQ4 2020: $25mQ1 2021: $13m21Q2 2021: $24mQ3 2021: $48mQ4 2021: $57mQ1 2022: $34m22Q2 2022: $42mQ3 2022: $86mQ4 2022: $44mQ1 2023: $57m23Q2 2023: $45mQ3 2023: $13mQ1 2024: $23m24Q2 2024: $15mQ3 2024: $3.4mQ4 2024: $30mQ1 2025: $12m25Q2 2025: $63mQ3 2025: $64mQ4 2025: $85mQ1 2026: $118m26Q2 2026: $112m
  • Q4 2020: $25m
  • Q1 2021: $13m
  • Q2 2021: $24m
  • Q3 2021: $48m
  • Q4 2021: $57m
  • Q1 2022: $34m
  • Q2 2022: $42m
  • Q3 2022: $86m
  • Q4 2022: $44m
  • Q1 2023: $57m
  • Q2 2023: $45m
  • Q3 2023: $13m
  • Q1 2024: $23m
  • Q2 2024: $15m
  • Q3 2024: $3.4m
  • Q4 2024: $30m
  • Q1 2025: $12m
  • Q2 2025: $63m
  • Q3 2025: $64m
  • Q4 2025: $85m
  • Q1 2026: $118m
  • Q2 2026: $112m

Between the quarter ends of Q1 2026 and Q2 2026. Each change in shares is valued at the Q2 2026 price, so the price’s own move is left out; a 13F shows the two quarter ends, not when in between anything was bought or sold.

Started in Q2 2026

Largest increases, by shares

Largest decreases, by shares

No manager on file sold part of it.

ManagerValue over timeFirst listedLargestQ2 2026
D. E. Shaw & Co.Q2 2026$104m$104m
Holocene Advisors LPQ3 2022$23m$4.3m
PDT Partners LLCQ4 2022$5.0m$4.1m
Point72 Asset Management LPQ4 2020$72mlast listed Q2 2025
Marshall Wace LLPQ1 2023$57mlast listed Q1 2026
Janus Henderson Group LtdQ2 2025$53mlast listed Q1 2026
Voloridge Investment Management LLCQ3 2025$27mlast listed Q1 2026
Farallon Capital Management LLCQ1 2024$18mlast listed Q1 2026
Woodline Partners LPQ3 2022$11mlast listed Q1 2025
ExodusPoint Capital Management LPQ2 2024$10mlast listed Q2 2024
Schonfeld Strategic Advisors LLCQ2 2025$7.3mlast listed Q2 2025
Hudson Bay Capital Management LPQ1 2024$2.2mlast listed Q1 2024
Walleye Capital LLCQ4 2021$1.7mlast listed Q1 2022

What ARQT is worth

Knowing who owns it is half the question. The other half is what it is worth against the companies it trades beside, which is the one an interviewer will follow up with.

Build the comp set around ARQT →

How much of the picture this is

A Form 13F reports US-listed long equity and nothing else: no shorts, no bonds, no cash and no non-US listings. It arrives forty-five days after the quarter ends, so a manager who sold in July still shows the position in a filing published in August. This page reads the managers on file here rather than every filer in the market, and each manager’s largest positions rather than the whole table, so a small position in a very large book may not appear. Say “their last filing showed” rather than “they own”, and the distinction will do you credit.

What to do with a name the funds are buying

Knowing who owns something is the start of a pitch, not the pitch. The next questions are what it is worth and why they were buying.

Company names, tickers and logos are the trademarks of their respective owners and appear here to identify the company whose public figures are being used. L3VLUP is not affiliated with, sponsored by or endorsed by any company shown, and nothing here is a statement by or about that company. More

The holdings, every quarter, and the week between

One email a week on what moved in the market and what it means for the people interviewing into it, with the 13F changes the quarter they are filed.

One email a week, free, and you can leave at any point.